Simplex Trading’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $42K | Buy |
2,500
+2,300
| +1,150% | +$41.2K | ﹤0.01% | 6059 |
|
|
2025
Q4 | $3.21K | Sell |
200
-3,500
| -95% | -$52.1K | ﹤0.01% | 7651 |
|
|
2025
Q3 | $45K | Buy |
3,700
+2,500
| +208% | +$29.3K | ﹤0.01% | 6563 |
|
|
2025
Q2 | $13K | Buy |
1,200
+800
| +200% | +$9.49K | ﹤0.01% | 7094 |
|
|
2025
Q1 | $5K | Hold |
400
| – | – | ﹤0.01% | 7523 |
|
|
2024
Q4 | $6K | Sell |
400
-50,400
| -99% | -$972K | ﹤0.01% | 7484 |
|
|
2024
Q3 | $941K | Sell |
50,800
-400
| -0.8% | -$8.03K | ﹤0.01% | 2966 |
|
|
2024
Q2 | $1.04M | Sell |
51,200
-600
| -1% | -$10.6K | ﹤0.01% | 2873 |
|
|
2024
Q1 | $884K | Buy |
51,800
+51,600
| +25,800% | +$812K | ﹤0.01% | 3247 |
|
|
2023
Q4 | $3K | Hold |
200
| – | – | ﹤0.01% | 8057 |
|
|
2023
Q3 | $4K | Sell |
200
-1,700
| -89% | -$41.7K | ﹤0.01% | 7737 |
|
|
2023
Q2 | $44K | Sell |
1,900
-2,300
| -55% | -$52K | ﹤0.01% | 5957 |
|
|
2023
Q1 | $92K | Sell |
4,200
-2,100
| -33% | -$49.1K | ﹤0.01% | 5240 |
|
|
2022
Q4 | $127K | Buy |
6,300
+5,800
| +1,160% | +$112K | ﹤0.01% | 4783 |
|
|
2022
Q3 | $6K | Sell |
500
-11,200
| -96% | -$189K | ﹤0.01% | 8621 |
|
|
2022
Q2 | $231K | Sell |
11,700
-1,500
| -11% | -$39.8K | ﹤0.01% | 4429 |
|
|
2022
Q1 | $417K | Buy |
13,200
+400
| +3% | +$11.2K | ﹤0.01% | 4075 |
|
|
2021
Q4 | $285K | Buy |
12,800
+4,800
| +60% | +$125K | ﹤0.01% | 4645 |
|
|
2021
Q3 | $312K | Hold |
8,000
| – | – | ﹤0.01% | 4848 |
|
|
2021
Q2 | $311K | Buy |
8,000
+7,950
| +15,900% | +$285K | ﹤0.01% | 4921 |
|
|
2021
Q1 | $143K | Sell |
50
-43
| -46% | -$1.47K | ﹤0.01% | 5243 |
|
|
2020
Q4 | $246K | Sell |
93
-20
| -18% | -$408 | ﹤0.01% | 4333 |
|
|
2020
Q3 | $172K | Sell |
113
-12
| -10% | -$252 | ﹤0.01% | 4296 |
|
|
2020
Q2 | $254K | Sell |
125
-89
| -42% | -$1.59K | ﹤0.01% | 3722 |
|
|
2020
Q1 | $221K | Sell |
214
-44
| -17% | -$1.23K | ﹤0.01% | 3476 |
|
|
2019
Q4 | $971K | Buy |
258
+177
| +219% | +$7.95K | ﹤0.01% | 2117 |
|
|
2019
Q3 | $377K | Sell |
81
-4
| -5% | -$186 | ﹤0.01% | 2912 |
|
|
2019
Q2 | $444K | Buy |
85
+64
| +305% | +$3.75K | ﹤0.01% | 2681 |
|
|
2019
Q1 | $144K | Buy |
21
+16
| +320% | +$1.07K | ﹤0.01% | 3948 |
|
|
2018
Q4 | $29K | Sell |
5
-106
| -95% | -$9.15K | ﹤0.01% | 5016 |
|
|
2018
Q3 | $1.28M | Buy |
111
+73
| +192% | +$8.24K | ﹤0.01% | 1632 |
|
|
2018
Q2 | $479K | Buy |
38
+14
| +58% | +$1.7K | ﹤0.01% | 2498 |
|
|
2018
Q1 | $3K | Sell |
24
-76
| -76% | -$8.41K | ﹤0.01% | 4952 |
|
|
2017
Q4 | $211K | Buy |
100
+83
| +488% | +$8.28K | 0.01% | 1232 |
|
|
2017
Q3 | $5K | Sell |
17
-1
| -6% | -$97 | ﹤0.01% | 4354 |
|
|
2017
Q2 | $1K | Sell |
18
-79
| -81% | -$8.52K | ﹤0.01% | 5543 |
|
|
2017
Q1 | $25K | Buy |
97
+40
| +70% | +$4.65K | ﹤0.01% | 3023 |
|
|
2016
Q4 | $21K | Buy |
57
+14
| +33% | +$1.55K | ﹤0.01% | 2989 |
|
|
2016
Q3 | $13K | Sell |
43
-141
| -77% | -$16.2K | ﹤0.01% | 3367 |
|
|
2016
Q2 | $72K | Sell |
184
-101
| -35% | -$12.2K | ﹤0.01% | 1726 |
|
|
2016
Q1 | $106K | Buy |
285
+195
| +217% | +$20.3K | 0.01% | 1305 |
|
|
2015
Q4 | $3K | Sell |
90
-45
| -33% | -$5.15K | ﹤0.01% | 4201 |
|
|
2015
Q3 | $4K | Buy |
135
+31
| +30% | +$3.37K | ﹤0.01% | 4122 |
|
|
2015
Q2 | $49K | Buy |
104
+84
| +420% | +$10.2K | ﹤0.01% | 1708 |
|
|
2015
Q1 | $4K | Buy |
+20
| New | +$2.13K | ﹤0.01% | 3630 |
|
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Simplex Trading's CLB Position: Q2 2025 in Review
Simplex Trading sold out of Core Laboratories (CLB) in Q2 2025, closing a stake of 12,946 shares — an estimated $154K sold.
Simplex Trading first reported a position in CLB in Q1 2015 and held it in 24 quarters. The position peaked at $925K in Q3 2019. 191 funds tracked by Wall St. Rank hold CLB as of Q2 2025.
- Simplex Trading reported no remaining Core Laboratories position as of Q2 2025 after selling out during the quarter.
- Simplex Trading sold 12,946 Core Laboratories shares in Q2 2025, an estimated $154K.
- Simplex Trading first reported a position in Core Laboratories in Q1 2015 and held it in 24 quarters.
- Simplex Trading's Core Laboratories position peaked at $925K in Q3 2019.
- 191 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2025.
Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.